Modified GRF 1-29 & GHRP-2 and Bone Mineral Density GHRH analogs, through their Insulin-Like-Growth Factor 1(IGF-1) mediated actions are believed to enhance proliferation, differentiation, and survival of bone-forming cells
This technique measures key kinetic parameters such as the association rate (k_on), dissociation rate (k_off), and equilibrium dissociation constant (K_D) across a range of pH buffers (e.g., from pH 7.4 to 5.5)
$ 7.120 PUM: $ 14.24 ml PROCTER & GAMBLE COLOMBIA
Documented in animal-model literature for tissue remodeling, GI mucosal barrier signaling, and the cytoprotection paradigm
Suggested to use
Research Applications Tendon, ligament and soft-tissue repair models in preclinical investigation Gastrointestinal mucosal protection and ulcer-healing pathway studies Angiogenesis and growth-factor signalling characterisation in vitro Gut-brain axis and neurobehavioural response research Specification Identity: BPC-157 (CAS 137525-51-0) Molecular weight: 1419.55 g/mol Purity: 99%+ verified by HPLC and Mass Spectrometry Format: lyophilised peptide vial reconstitute with bacteriostatic water before use Storage: store lyophilised at -20C